Cargando…
Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells
Bone metastases represent common long term complications of patients with breast cancer. Zoledronic acid, an amino-bisphosphonate and mevalonate pathway inhibitor, is an established agent for the treatment of bone metastases. Direct antitumor effects of zoledronic acid have been proposed in breast c...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723419/ https://www.ncbi.nlm.nih.gov/pubmed/26909293 http://dx.doi.org/10.1016/j.jbo.2014.02.001 |